{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:47:00Z","timestamp":1789001220432,"version":"build-2803163510"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/ajg.2017.440","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T08:01:05Z","timestamp":1513065665000},"page":"254-264","source":"Crossref","is-referenced-by-count":87,"title":["Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome"],"prefix":"10.14309","volume":"113","author":[{"given":"Maren H","family":"Harms","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Thorburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Corpechot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry L A","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier M","family":"Battezzati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Nevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarosa","family":"Floreani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyriel Y","family":"Ponsioen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlyn J","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N","family":"Dalekos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Par\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Verhelst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris V","family":"Kowdley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorn C","family":"Goet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon M","family":"Hirschfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina E","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk R","family":"van Buuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210210","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis.","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"R2-19-20210210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis.","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"R3-19-20210210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases.","volume":"51","year":"2009","journal-title":"J Hepatol"},{"issue":"Suppl S1","key":"R4-19-20210210","first-page":"71","article-title":"Guidelines for the management of primary biliary cirrhosis: The Intractable Hepatobiliary Disease Study Group supported by the Ministry of Health, Labour and Welfare of Japan.","volume":"44","year":"2014","journal-title":"Hepatol Res"},{"key":"R5-19-20210210","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"R6-19-20210210","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1572-0241.2006.00634.x","article-title":"Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.","volume":"101","author":"Shi","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R7-19-20210210","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis.","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"R8-19-20210210","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"R9-19-20210210","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","article-title":"Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome.","volume":"55","author":"Corpechot","year":"2011","journal-title":"J Hepatol"},{"key":"R10-19-20210210","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"key":"R11-19-20210210","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis.","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R13-19-20210210","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid.","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"key":"R14-19-20210210","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrgastro.2015.187","article-title":"Primary biliary cirrhosis: Renaming primary biliary cirrhosis-clarity or confusion?","volume":"12","author":"Trivedi","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R16-19-20210210","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2014.01.029","article-title":"Optimising risk stratification in primary biliary cirrhosis: ASTplatelet ratio index predicts outcome independent of ursodeoxycholic acid response.","volume":"60","author":"Trivedi","year":"2014","journal-title":"J Hepatol"},{"key":"R17-19-20210210","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/gast.2002.31880","article-title":"Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients.","volume":"122","author":"Corpechot","year":"2002","journal-title":"Gastroenterology"},{"key":"R18-19-20210210","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/hep.510230108","article-title":"Time course of histological progression in primary biliary cirrhosis.","volume":"23","author":"Locke","year":"1996","journal-title":"Hepatology"},{"key":"R19-19-20210210","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.510290301","article-title":"Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.","volume":"29","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"R20-19-20210210","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/00365520510023215","article-title":"Survival following the development of ascites andor peripheral oedema in primary biliary cirrhosis: a staged prognostic model.","volume":"40","author":"Chan","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"R21-19-20210210","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/MEG.0b013e328320005f","article-title":"Variceal bleeding in primary biliary cirrhosis patients: a subgroup with improved prognosis and a model to predict survival after first bleeding.","volume":"21","author":"Vlachogiannakos","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R22-19-20210210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2036.2009.04215.x","article-title":"Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach.","volume":"31","author":"Chan","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-19-20210210","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3748\/wjg.v19.i7.1111","article-title":"Risk factors for hepatic decompensation in patients with primary biliary cirrhosis.","volume":"19","author":"Shi","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R24-19-20210210","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.jhep.2014.07.036","article-title":"ASTplatelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis.","volume":"61","author":"Joshita","year":"2014","journal-title":"J Hepatol"},{"key":"R25-19-20210210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/03009734.2014.985763","article-title":"Predictors of liver failure in primary biliary cirrhosis.","volume":"120","author":"Zhao","year":"2015","journal-title":"Ups J Med Sci"},{"key":"R26-19-20210210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jhep.2013.04.010","article-title":"A validated clinical tool for the prediction of varices in PBC: The Newcastle Varices in PBC Score.","volume":"59","author":"Patanwala","year":"2013","journal-title":"J Hepatol"},{"key":"R27-19-20210210","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.arcmed.2006.08.005","article-title":"Liver biopsy assessment in chronic hepatitis.","volume":"38","author":"Lefkowitch","year":"2007","journal-title":"Arch Med Res"},{"key":"R28-19-20210210","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1572-0241.2006.00699.x","article-title":"Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.","volume":"101","author":"ter Borg","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R29-19-20210210","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: an international follow-up study.","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"key":"R30-19-20210210","first-page":"250A","article-title":"Validation of alkaline phosphatase and bilirubin values as a surrogate endpoint in primary biliary cirrhosisan international, collaborative study.","volume":"58","author":"Lammers","year":"2013","journal-title":"Hepatology"},{"key":"R31-19-20210210","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis.","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"key":"R32-19-20210210","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/sim.2712","article-title":"Tutorial in biostatistics: competing risks and multi-state models.","volume":"26","author":"Putter","year":"2007","journal-title":"Stat Med"},{"key":"R34-19-20210210","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls.","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"key":"R36-19-20210210","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/01621459.1996.10476908","article-title":"Multiple imputation after 18 years.","volume":"91","author":"Rubin","year":"1996","journal-title":"J Am Stat Assoc"},{"key":"R37-19-20210210","doi-asserted-by":"crossref","first-page":"e0123489","DOI":"10.1371\/journal.pone.0123489","article-title":"A systematic model specification procedure for an illness-death model without recovery.","volume":"10","author":"Eulenburg","year":"2015","journal-title":"PLoS ONE"},{"key":"R38-19-20210210","first-page":"289","article-title":"Report of the Baveno VI Consensus Workshop.","volume":"15","author":"Cardenas","year":"2016","journal-title":"Ann Hepatol"},{"key":"R39-19-20210210","first-page":"249A","article-title":"Defining optimal laboratory response cirteria in UDCA treated primary biliary cirrhosis. Results of an international multicenter long-term follow-up study.","volume":"58","author":"Lammers","year":"2013","journal-title":"Hepatology"},{"key":"R40-19-20210210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","article-title":"Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study.","volume":"65","author":"Trivedi","year":"2015","journal-title":"Gut"},{"key":"R41-19-20210210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.","volume":"44","author":"DAmico","year":"2006","journal-title":"J Hepatol"},{"key":"R42-19-20210210","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/hep.20339","article-title":"Improved survival after variceal bleeding in patients with cirrhosis over the past two decades.","volume":"40","author":"Carbonell","year":"2004","journal-title":"Hepatology"},{"key":"R43-19-20210210","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1055\/s-0032-1301734","article-title":"Acute variceal bleeding.","volume":"33","author":"Garcia-Pagan","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"key":"R44-19-20210210","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01320309","article-title":"Survival and prognostic indicators in compensated and decompensated cirrhosis.","volume":"31","author":"DAmico","year":"1986","journal-title":"Dig Dis Sci"},{"key":"R45-19-20210210","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840070124","article-title":"Compensated cirrhosis: natural history and prognostic factors.","volume":"7","author":"Gines","year":"1987","journal-title":"Hepatology"},{"key":"R46-19-20210210","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jhep.2004.01.005","article-title":"Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients.","volume":"40","author":"Planas","year":"2004","journal-title":"J Hepatol"},{"key":"R47-19-20210210","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study.","volume":"51","author":"Jepsen","year":"2010","journal-title":"Hepatology"},{"key":"R48-19-20210210","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years.","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology"},{"key":"R49-19-20210210","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(92)90771-P","article-title":"Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis.","volume":"102","author":"Colina","year":"1992","journal-title":"Gastroenterology"},{"key":"R50-19-20210210","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0168-8278(87)80035-1","article-title":"Portal hypertension in primary biliary cirrhosis. Relationship with histological features.","volume":"5","author":"Navasa","year":"1987","journal-title":"J Hepatol"},{"key":"R51-19-20210210","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2008.07.019","article-title":"Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment.","volume":"135","author":"Huet","year":"2008","journal-title":"Gastroenterology"},{"key":"R52-19-20210210","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/0016-5085(89)90526-X","article-title":"Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival.","volume":"96","author":"Gores","year":"1989","journal-title":"Gastroenterology"},{"key":"RU54-19-20210210","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000434-201802000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:20:54Z","timestamp":1786548054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201802000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2017.440","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}